All data are based on the daily closing price as of June 6, 2025
b

Bora Pharmaceuticals

6472.TW
27.73 USD
-0.12
-0.43%

Overview

Last close
27.73 usd
Market cap
2.81B usd
52 week high
28.88 usd
52 week low
18.84 usd
Target price
32.6 usd

Valuation

P/E
15.5024
Forward P/E
N/A
Price/Sales
4.1156
Price/Book Value
6.5566
Enterprise Value
3.30B usd
EV/Revenue
4.7277
EV/EBITDA
11.3592

Key financials

Revenue TTM
697.46M usd
Gross Profit TTM
270.51M usd
EBITDA TTM
137.82M usd
Earnings per Share
1.79 usd
Dividend
0.47 usd
Total assets
1.37B usd
Net debt
394.39M usd

About

Bora Pharmaceuticals Co., LTD. researches and develops, manufactures, distributes, and sells pharmaceuticals worldwide. The company operates through Sales, Contract Development & Manufacturing Organization, and Other segments. It manufactures and sells generic, brand, and over the counter (OTC) drugs. The company also offers contract development and manufacturing services, including clinical and commercial manufacturing, pharmaceutical development, packaging and serialization, analytical and microbiology testing, and regulatory affairs services. In addition, it provides food and vitamin supplements, and skincare products; and biotechnical services. The company sells its products directly to clinics, pharmacies, pharmacy chains, and drug stores, as well as through distributors to medical centers, corporate and public hospitals, and regional and district hospitals. Bora Pharmaceuticals Co., LTD. was incorporated in 2007 and is based in Taipei City, Taiwan.
  • Symbol
    6472.TW
  • Exchange
    TW
  • Isin
    TW0006472004
  • Country
    Taiwan
  • Sector
    Healthcare
  • Industry
    Drug Manufacturers - Specialty & Generic
  • CEO
  • Headquarter
    Taipei
  • Web site
    https://www.bora-corp.com
Jakota Newsletter

Stay ahead in the JAKOTA stock markets with our roundup of vital insights

Icon scroll to top